(Q53636518)

16 May 2018

title

Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. (English)

1 reference

16 May 2018

author name string

Yoo JH

1

1 reference

16 May 2018

Lee DG

2

1 reference

16 May 2018

Choi SM

3

1 reference

16 May 2018

Choi JH

4

1 reference

16 May 2018

Park YH

5

1 reference

16 May 2018

Kim YJ

6

1 reference

16 May 2018

Kim HJ

7

1 reference

16 May 2018

Lee S

8

1 reference

16 May 2018

Kim DW

9

1 reference

16 May 2018

Lee JW

10

1 reference

16 May 2018

Min WS

11

1 reference

16 May 2018

Shin WS

12

1 reference

16 May 2018

Kim CC

13

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 September 2004

1 reference

16 May 2018

Bone Marrow Transplantation

published in

1 reference

16 May 2018

volume

34

1 reference

16 May 2018

issue

6

1 reference

16 May 2018

page(s)

497-504

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704636

exact match

0 references

cites work

Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Incidence of sepsis after peripheral blood progenitor cells transplantation: analysis of 86 consecutive hemato oncological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Infections following hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Definitions of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Bone-marrow transplantation (second of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Invasive mold infections in allogeneic bone marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Antifungal chemoprophylaxis after blood and marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Infection with varicella-zoster virus after marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Five cases of cytomegalovirus infection detected by in situ hybridization and antigenemia assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Tuberculosis in hematopoietic stem cell transplant recipients in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Measles in bone marrow transplant recipients during an outbreak in São Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Increased incidence of CMV infection after allogeneic bone marrow transplantation from unrelated donors but doubts about an increase in CMV-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Genetic and antigenic characterization of measles viruses that circulated in Korea during the 2000-2001 epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Antifungal Prophylaxis in Severely Neutropenic Patients: How Much Fluconazole is Necessary?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Pulmonary tuberculosis in allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704636

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704636

1 reference

16 May 2018

1 reference

16 May 2018